A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors	Advanced Solid Tumors	Not yet recruiting	Phase 1 / Phase 2	2026-04-13		NCT07509684

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Zhejiang Anglikang Pharmaceutical Co., Ltd.	2

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials